WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a therapeutics company focused on discovering and developing novel gene control therapies, announced today that representatives from the company will be presenting at three investor conferences during the month of March.
- Cowen & Co. 35th Annual Health Care Conference, The Boston Marriott Copley Place, Boston, March 4, 2015 at 9:30 a.m. ET
- BioCentury 22nd Annual Future Leaders in the Biotech Industry, Millennium Broadway Hotel and Conference Center, New York City, March 20, 2015 at 10:30 a.m. ET
- JMP Life Sciences Private Company Conference, Le Parker Meridien Hotel, New York City, March 27, 2015
About Syros Pharmaceuticals
Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics and biomarkers. The Company’s founders are pioneers in gene control research and translation. Co-founded by Flagship Ventures and ARCH Venture Partners, Syros Pharmaceuticals is located in Watertown, MA. For more information, visit www.syros.com.